Suntornlohanakul Onnicha, Leelawattana Rattana
Endocrinology and Metabolism Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Thailand.
Endocrinology and Metabolism Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Thailand.
Int J Surg Case Rep. 2020;71:183-186. doi: 10.1016/j.ijscr.2020.04.021. Epub 2020 May 7.
Recurrent hyperparathyroidism is difficult to manage due to the difficulty in finding the missing adenoma. Herein we present a case of recurrent hyperparathyroidism from ectopic adenomas which basic investigations failed to locate but were finally localized by a 4DCT following selective venous sampling (SVS) of parathyroid hormone (PTH).
A young female presented with recurrent hyperparathyroidism. She had severe primary hyperparathyroidism and temporary normocalcemia after first parathyroidectomy. Her hypercalcemia recurred and required second operation. However, the second operation was unsuccessful due to the pre-operation ultrasound, computed tomography (CT) neck, and sestamibi failed to identify the culprit parathyroid adenoma. After the second operation, positron emission tomography (PET), CT neck and sestamibi failed to identify the tumor but a sequence of SVS PTH and four-dimensional computed tomography (4DCT) successfully identified several ectopic adenomas.
Ectopic parathyroid tissue is the most common cause of recurrent hyperparathyroidism but precisely locating these ectopic glands is often challenging. Despite modern modalities such as PET scans, the success rate is not impressive. SVS PTH is a good method to regionalize the ectopic source of PTH. With the more specified area, fine-tuning imaging with a 4DCT can identify the specific location of the ectopic parathyroid tissue.
A sequence of SVS PTH followed by 4DCT could identify the exact location of ectopic parathyroid adenomas in a patient when conventional non-invasive imaging studies failed.
由于难以找到缺失的腺瘤,复发性甲状旁腺功能亢进症难以处理。在此,我们报告一例异位腺瘤导致的复发性甲状旁腺功能亢进症病例,基础检查未能定位腺瘤,但在甲状旁腺激素(PTH)选择性静脉采样(SVS)后通过4DCT最终确定了其位置。
一名年轻女性患有复发性甲状旁腺功能亢进症。她患有严重的原发性甲状旁腺功能亢进症,首次甲状旁腺切除术后出现暂时的血钙正常。她的高钙血症复发,需要进行第二次手术。然而,由于术前超声、颈部计算机断层扫描(CT)和甲氧基异丁基异腈显像均未能识别出甲状旁腺腺瘤,第二次手术未成功。第二次手术后,正电子发射断层扫描(PET)、颈部CT和甲氧基异丁基异腈显像均未能识别出肿瘤,但一系列甲状旁腺激素选择性静脉采样(SVS)和四维计算机断层扫描(4DCT)成功识别出了几个异位腺瘤。
异位甲状旁腺组织是复发性甲状旁腺功能亢进症最常见的原因,但精确定位这些异位腺体通常具有挑战性。尽管有PET扫描等现代检查手段,但其成功率并不理想。甲状旁腺激素选择性静脉采样(SVS)是确定甲状旁腺激素异位来源区域的一种好方法。在确定了更具体的区域后,通过4DCT进行精确成像可以识别异位甲状旁腺组织的具体位置。
当传统的非侵入性成像研究失败时,一系列甲状旁腺激素选择性静脉采样(SVS)后进行4DCT可以确定患者异位甲状旁腺腺瘤的确切位置。